Condition

Hyponatremia

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 19 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials19
Recruiting1
Common interventions20
Lead sponsors shown15
Advertisement

Clinical trials

19 shown
Protein Supplementation in Hyponatremia Due to the Syndrome of Inappropriate AntidiuresisNCT06821802 · 2025-04-14
RECRUITING
Saline Infusion Test in HyponatremiaNCT06498856 · 2024-07-01
NOT_YET_RECRUITING
Cicletanine in Hypertension With Diabetes: Added Magnesium Preserves Potassium and SodiumNCT02709031 · 2022-06-01
UNKNOWN
Hypotonic Hyponatremia: Criteria for the Correct Classification of Its Etiology and of Patient Volume StatusNCT04402190 · 2018-06-01
COMPLETED
Tolvaptan for Advanced or Refractory Heart FailureNCT02959411 · 2016-10-01
TERMINATED
Protein Supplementation in Thiazide-induced HyponatremiaNCT02614807 · 2016-06-01
WITHDRAWN
Regional Tolvaptan RegistryNCT02666651 · 2016-05-01
UNKNOWN
Tolvaptan for Hyponatremia in Cirrhotic Patients With AscitesNCT01716611 · 2012-11-01
UNKNOWN
The Effect of Fluid Restriction in Congestive Heart Failure Complicated With HyponatremiaNCT01748331 · 2012-11-01
UNKNOWN
V2 Receptor Effects on Fluid Regulation and PerformanceNCT02084797 · 2011-06-01
COMPLETED
Tolvaptan for In-hospital HyponatremiaNCT01386372 · 2011-06-01
TERMINATED
Safety and Efficacy of Conivaptan in Hyponatremic Patients With Symptomatic Acute Decompensated Heart Failure (ADHF)NCT00843986 · 2009-04-01
TERMINATED
Tolvaptan Versus Fluid Restriction in SIADHNCT04119206 · 2009-01-01
COMPLETED
Subclassification of the Syndrome of Inappropriate ADH SecretionNCT01341665 · 2008-03-01
COMPLETED
Hypertonic Saline Solution in Heart FailureNCT00555685 · 2008-02-01
COMPLETED
THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient EvaluationNCT00578695 · 2007-01-01
COMPLETED
Maintenance Intravenous Fluids in ChildrenNCT00621348 · 2006-09-01
COMPLETED
Study of Ascending Levels of Tolvaptan in HyponatremiaNCT00201994 · 2003-11-01
COMPLETED
Study of IV YM087 to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic HyponatremiaNCT00380575 · 2000-08-01
COMPLETED

Leading sponsors

Trial status mix

COMPLETED9
UNKNOWN4
TERMINATED3
NOT_YET_RECRUITING1
RECRUITING1
WITHDRAWN1

Phase mix

PHASE35
NA4
PHASE23
PHASE43
PHASE11
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.